| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |